Trans-Arterial Chemo Embolisation (DC Bead) of a Hepatoma
Jakub Wiskirchen, MD, Gunnar Tepe, MD, and Philippe L. Pereira, MD
Department for Diagnostic and Interventional Radiology University Hospital Tübingen, Germany
Patient History
Male patient (53 y, HCV positive) with a well circumscribed, hypervascular HCC in the right lobe in liver MR (Fig 1). • Angiography with a 4Fr C2 Cobra™ (Cook®) catheter (Fig 2) confirmed the presence of a hypervascular lesion.
Procedure
After applying 2ml DC Bead™ (Biocompatibles) and 50mg epirubicin (Pfizer) to the tumour and the surrounding tissue via a 2.7Fr microcatheter system (Progreat™, Terumo®) the tumour did not opacify (Figs 3 and 4).
Outcome
A control CT scan, obtained one day after PRECISION TACE confirmed the embolisation of the tumour. The air bubbles within the tumour are regular findings following embolisation with DC Bead™ and do not represent a complication (Figs 5 and 6).
DC Bead Sizes and Label Colours
| Bead size & label colour | Volume of beads |
Product code | Time to >90% loading | Time to 98% loading |
|---|---|---|---|---|
| 100-300µm | 2ml | DC2V103 | 5 mins | 20 mins |
| 300-500µm | 2ml | DC2V305 | 10 mins | 40 mins |
| 500-700µm | 2ml | DC2V507 | 20 mins | 75 mins |
| 700-900µm | 2ml | DC2V709 | 30 mins | 100 mins |
In this section
Disclaimer
The products may not be available for sale, may not be registered, approved or cleared for use as claimed, in all countries where Biocompatibles is represented.